FHTX
#3156
Foghorn Therapeutics Inc. - Common Stock
6.0 0 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.54%
Monthly Change
+16.73%
6 month change
+9.09%
Year Change
+47.06%
Previous Close
6.2 2
Open
6.0 1
Low
5.9 6
High
6.0 4
Volume
157
Financials
- Market Capitalization 356.31 M
- Employee 106
- Founded 2015
- CEO N/A
- Website www.foghorntx.com
- Headquarter Delaware, United States
- FIGI BBG00HFZPB88
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.58
Price to sales ratio
11
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3109 |  EYPT EyePoint, Inc. - Common Stock | 4.47 USD | -3.46% | -15.98% | -62.69% | -62.75% | 385.37 M USD | ||
| 3138 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.03 USD | -8.97% | -1.93% | -0.49% | +298.04% | 367.58 M USD | ||
| 3162 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.52 USD | -0.62% | -6.50% | +12.56% | -39.98% | 355.81 M USD | ||
| 3189 |  PALI Palisade Bio, Inc. - Common Stock | 2.01 USD | -4.74% | -4.29% | -0.50% | +18.24% | 350.28 M USD |
Frequently asked questions about Foghorn Therapeutics Inc. Common Stock
What is the Foghorn Therapeutics Inc. Common Stock stock price today?
The current price of Foghorn Therapeutics Inc. Common Stock (FHTX) is 6.00. Over the past 24 hours, the stock has changed by -3.54%. Follow the FHTX chart for real-time price dynamics.
What is the stock ticker of Foghorn Therapeutics Inc. Common Stock?
Foghorn Therapeutics Inc. Common Stock trades under the ticker FHTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Foghorn Therapeutics Inc. Common Stock stock going up?
FHTX has changed by -15.13% over the last week, +16.73% over the last month, and +47.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Foghorn Therapeutics Inc. Common Stock?
Foghorn Therapeutics Inc. Common Stock currently has a market capitalization of 356.31 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Foghorn Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Foghorn Therapeutics Inc. Common Stock reported earnings of -0.1 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Foghorn Therapeutics Inc. Common Stock revenue for the last quarter?
Foghorn Therapeutics Inc. Common Stock reported quarterly revenue of 16.07 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Foghorn Therapeutics Inc. Common Stock net income for the last quarter?
Foghorn Therapeutics Inc. Common Stock reported net income of -7.19 M for the last quarter. The previous quarter showed -19.88 M, which means net income changed by +63.82%.
How many employees does Foghorn Therapeutics Inc. Common Stock have?
As of the latest available data, Foghorn Therapeutics Inc. Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Foghorn Therapeutics Inc. Common Stock EBITDA?
Foghorn Therapeutics Inc. Common Stock EBITDA is -8.61 M, and its EBITDA margin is -53.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Foghorn Therapeutics Inc. Common Stock stock?
You can buy Foghorn Therapeutics Inc. Common Stock (FHTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Foghorn Therapeutics Inc. Common Stock stock?
Investing in Foghorn Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FHTX chart and related analysis on metatrader.com as part of your research.